Immunovant IMVT
NASDAQ IMVT
$28.36 -0.23 (-0.79%)
As of: Oct 21, 2026 · 3:59 PM EDT

Immunovant (IMVT) Ending Cash Balance (2018 - 2026)

Updated

Analysis

Immunovant (IMVT) Ending Cash Balance (2018 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Ending Cash Balance (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 20.42 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 6.57 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 6.89 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 7.62 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 4.88 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 3.18 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 1.03 Bn
10 Immunovant 5.85 Bn 2.63 Bn - 797.80 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 797.80 Mn
Mar 31, 2026 902.11 Mn
Dec 31, 2025 994.53 Mn
Sep 30, 2025 521.87 Mn
Jun 30, 2025 598.91 Mn
Mar 31, 2025 713.97 Mn
Dec 31, 2024 374.69 Mn
Sep 30, 2024 472.94 Mn
Jun 30, 2024 560.01 Mn
Mar 31, 2024 635.37 Mn
Dec 31, 2023 690.94 Mn
Sep 30, 2023 269.93 Mn
Jun 30, 2023 329.96 Mn
Mar 31, 2023 376.53 Mn
Dec 31, 2022 432.61 Mn
Sep 30, 2022 405.77 Mn
Jun 30, 2022 427.21 Mn
Mar 31, 2022 493.82 Mn
Dec 31, 2021 527.00 Mn
Sep 30, 2021 558.95 Mn
API Access

Immunovant Ending Cash Balance API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=IMVT&period=max&api_key=YOUR_API_KEY